Evaluating the Safety and Immunogenicity of pDNA Vaccines Expressing HIV M Group p24^Gag Conserved Elements and/or p55^Gag, Administered With IL-12 pDNA by Intramuscular Electroporation, in Healthy, HIV-Uninfected Adults

Condition:   HIV Infections Interventions:   Biological: p24CE1/2 pDNA Vaccine;   Biological: p55^gag pDNA Vaccine;   Biological: IL-12 pDNA Adjuvant;   Biological: Placebo;   Device: Ichor Medical Systems Intramuscular TriGrid Delivery System (TDS-IM) electroporation (EP) device Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting - verified June 2017 (Source: ClinicalTrials.gov)

http://ift.tt/2t2Mrmm


http://ift.tt/2s4W46D

http://ift.tt/2rUL2iq


http://ift.tt/2reiAWC


http://ift.tt/2s56ZNT


http://ift.tt/2smDLKQ


http://ift.tt/2rJjXQW


http://ift.tt/2rJzPms


from ! Medicine by Alexandros G. Sfakianakis via Αλέξανδρος Σφακιανάκης on Inoreader http://ift.tt/2rar5XB
via IFTTT